Aconitum Napellus 30X

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Aconitum Napellus 30X
Generic name: ACONITUM NAPELLUS
Manufacturer: Laboratoire Schmidt-Nagel Inc.
Product type: HUMAN OTC DRUG
SPL set ID: 32fd6811-9ec9-7787-e063-6294a90aed2d
SPL ID: 359342d1-c262-b698-e063-6394a90ac612
Version: 2
Effective date: 2025-05-20
Source export date: 2026-09-28
Source partition: 1
Source file: https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/9c7783846d422acb0c9e59457606951c785a7d28cc631c8cc4839d0dc7c55f39/drug-label-0001-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:12:40

Harmonized routes table
Harmonized routes
ORAL, SUBLINGUAL

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Aconitum Napellus 30X	openfda.brand_name
generic name		ACONITUM NAPELLUS	openfda.generic_name
manufacturer name		Laboratoire Schmidt-Nagel Inc.	openfda.manufacturer_name
ndc	package	73296-001-01	openfda.package_ndc
ndc	product	73296-001	openfda.product_ndc
ndc11	package	73296000101	derived:openfda.package_ndc
spl id		359342d1-c262-b698-e063-6394a90ac612	id
spl set id		32fd6811-9ec9-7787-e063-6294a90aed2d	set_id
unii		U0NQ8555JD	openfda.unii

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

If symptoms worsen or persist for more than 7 days, consult a physician.

Adverse event summaries are temporarily unavailable. Other product information remains available.